These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 15372772)
1. Drug companies, doctors and disclosures. Tuorto S; Chan MK; Adusumilli PS Natl Med J India; 2004; 17(4):215-6. PubMed ID: 15372772 [No Abstract] [Full Text] [Related]
2. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward. Samson K Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337 [No Abstract] [Full Text] [Related]
3. Biased articles. Friedman JH Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378 [No Abstract] [Full Text] [Related]
4. Pharmaceuticals and medical devices: business practices. Issue brief. Thomson Reuters/West Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840 [No Abstract] [Full Text] [Related]
5. Individual wariness needed to spot biased drug research. Lazarus A Manag Care; 2005 Sep; 14(9):8, 13. PubMed ID: 16238253 [No Abstract] [Full Text] [Related]
6. America's other drug problem: how the drug industry distorts medicine and politics. Relman AS; Angell M New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803 [No Abstract] [Full Text] [Related]
7. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts. Brand R State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159 [No Abstract] [Full Text] [Related]
8. Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics. Connors AL Albany Law Rev; 2009 Sep; 73(1):243-82. PubMed ID: 20235401 [No Abstract] [Full Text] [Related]
9. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry. Dorfman HL; Reig LP Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876 [No Abstract] [Full Text] [Related]
10. Doctors face compulsory system to declare gifts and hospitality from drug companies. O'Dowd A BMJ; 2015 Aug; 351():h4617. PubMed ID: 26311722 [No Abstract] [Full Text] [Related]
11. The gift of drug samples. Reid EE Hastings Cent Rep; 2012; 42(2):49. PubMed ID: 22733332 [No Abstract] [Full Text] [Related]
12. Beyond government intervention: drug companies and bioethics. Dresser R Am J Bioeth; 2002; 2(3):42-3. PubMed ID: 12230855 [No Abstract] [Full Text] [Related]
13. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia. Wilson A Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745 [No Abstract] [Full Text] [Related]
14. Out in the open. Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130 [No Abstract] [Full Text] [Related]
15. Researchers raise concerns about secrecy in company-sponsored clinical trials. Mangan KS Chron High Educ; 2006 Apr; 52(31):A29. PubMed ID: 16789295 [No Abstract] [Full Text] [Related]
16. Ethical issues in the relationships involving medicine and industry. Thomas PS; Tan KS; Yates DH Intern Med J; 2005 Dec; 35(12):732. PubMed ID: 16313554 [No Abstract] [Full Text] [Related]
17. Beyond the naïve "no-see": ethical prescribing and the drive for pharmaceutical transparency. Oldani M PM R; 2009 Jan; 1(1):82-6. PubMed ID: 19627878 [No Abstract] [Full Text] [Related]
18. Drug companies will have to report all payments to US doctors from March 2014. Roehr B BMJ; 2013 Feb; 346():f826. PubMed ID: 23393117 [No Abstract] [Full Text] [Related]
19. Independent medical research. van der Meer JW; de Gier AM; van Swaaij WP; Katan MB Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759 [No Abstract] [Full Text] [Related]
20. For sale: physicians' prescribing data. Steinbrook R N Engl J Med; 2006 Jun; 354(26):2745-7. PubMed ID: 16807410 [No Abstract] [Full Text] [Related] [Next] [New Search]